Advertisement
"Building on the company's rich history and our 13-year track recordservicing healthcare clients across the country, our new name captures theessence of the technology-driven processes and fresh thinking that have beenthe hallmarks of our success," said David J. McLean, NovoLogix CEO.
Advertisement
From Latin, Novo means 'new, innovation'; Logix (or Logos) is taken fromGreek, meaning 'intelligent, smart, logic'.
Commenting on the reasons behind the change, McLean added, "Healthcare hasevolved dramatically over the past decade, particularly in the homehealth/ancillary care field: changing economic demands and governmentmandates, the flood of biopharmaceuticals in the market, shifting sites ofcare, and the administration support required for many of the new drugtherapies.
As a company, we have done much more than keep pace with the changes. Wehave helped our clients stay ahead of the curve. Now, given where we are inthe industry and where we are as a business, the time is right for us torename and rebrand the company in a way that more accurately reflects thevalue and benefits we provide to clients. The field has grown and needs havechanged, and there is more and more demand for our services and expertiseoutside of the ancillary space. We feel confident that the name and brandimage of NovoLogix translates our vision for the future into one clearmessage, while also acknowledging the core competencies and capabilities thathelped us get to where we are today."
Along with the name change, the company has adopted a new logo andbranding, and has unveiled a new web site at http://www.novologix.net. Newprovider and client sites are under development. And a marketing campaign viaprint, trade shows, and online media is planned to promote the NovoLogix brandthroughout 2008.
The company also recently announced a new business development initiativefocused on meeting the unique needs of federal- and state-level governmentprograms (e.g., Medicare and Medicaid) for value-driven electronic technologyservices to manage and re-price pharmaceuticals paid under the medicalbenefit. NovoLogix remains committed to providing current customers with thelatest technology and services to manage trend, maximize revenue, reducecosts, and eliminate administrative inefficiencies, and will continue to reachout to other commercial clients as well, including national health plans,pharmacy benefits management companies (PBMs), and pharmacy and devicemanufacturers.
"Our new name and new initiatives will drive our focus on the future andthe ways that we can help our clients exploit both existing and emergingtechnologies to fundamentally change the economics of America's healthcaresystem and keep us all moving forward," McLean concluded.
Company History
Beginning in 1995, co-founders Dave Willcutts and Tom McNulty built anorganization committed to providing an informational infrastructure formanaging and integrating all the varied and distinct facets of what was thenthe infancy of home care. A pioneer throughout the industry's developingyears as Ancillary Care Management, the company created new technology-drivenlogic and protocols for processing prior authorizations and a proprietary NDCto HCPCS Crosswalk Methodology that accurately and precisely prices claims-- in particular drugs, injectables, infusibles, and other pharmaceuticalspaid under the medical benefit. These two state-of-the-art technologyapplications serve as the foundation for the new NovoLogix -- a company thatwill drive healthcare innovation for decades to come.
NovoLogix Today
NovoLogix delivers technology applications, systems, and processes toposit
